Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Staskin

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Current Urology Reports|October 22, 2005
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?David R Staskin, Roger R Dmochowski, Alan J Wein
Current Urology Reports|October 21, 2006
Antimuscarinic therapy in men with bladder outlet obstructionDavid R Staskin, Steven A Kaplan, Alan J Wein
The Urologic Clinics of North America|December 13, 2002
Autologous and synthetic urethral slings for female incontinenceKathleen Niknejad, Louis S Plzak, David R Staskin, et al.
BJU International|August 17, 2006
Advances in female stress urinary incontinence: mid-urethral slingsTravis L Bullock, Gamal Ghoniem, Carl G Klutke, et al.
Urology|March 18, 2008
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional studyRoger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
Urology|March 9, 2010
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 gramsDoreen E Chung, Alexis E Te, David R Staskin, et al.
World Journal of Urology|August 20, 2009
Considerations for the management of urgency symptoms in patients with overactive bladder syndromeLinda D Cardozo, Philip E V A Van Kerrebroeck, David R Staskin
Clinical Drug Investigation|August 23, 2012
Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled studyGary G Kay, David R Staskin, Scott MacDiarmid, et al.
The Journal of Urology|March 20, 2012
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptomsDavid R Staskin, Martin C Michel, Franklin Sun, et al.
Current Urology Reports|August 16, 2012
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of careDavid R Staskin, Kenneth M Peters, Scott MacDiarmid, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Current Urology Reports|October 22, 2005
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?David R Staskin, Roger R Dmochowski, Alan J Wein
Current Urology Reports|October 21, 2006
Antimuscarinic therapy in men with bladder outlet obstructionDavid R Staskin, Steven A Kaplan, Alan J Wein
The Urologic Clinics of North America|December 13, 2002
Autologous and synthetic urethral slings for female incontinenceKathleen Niknejad, Louis S Plzak, David R Staskin, et al.
BJU International|August 17, 2006
Advances in female stress urinary incontinence: mid-urethral slingsTravis L Bullock, Gamal Ghoniem, Carl G Klutke, et al.
Urology|March 18, 2008
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional studyRoger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
Urology|March 9, 2010
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 gramsDoreen E Chung, Alexis E Te, David R Staskin, et al.
World Journal of Urology|August 20, 2009
Considerations for the management of urgency symptoms in patients with overactive bladder syndromeLinda D Cardozo, Philip E V A Van Kerrebroeck, David R Staskin
Clinical Drug Investigation|August 23, 2012
Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled studyGary G Kay, David R Staskin, Scott MacDiarmid, et al.
The Journal of Urology|March 20, 2012
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptomsDavid R Staskin, Martin C Michel, Franklin Sun, et al.
Current Urology Reports|August 16, 2012
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of careDavid R Staskin, Kenneth M Peters, Scott MacDiarmid, et al.
Pageof 6